GAYGF Stock News 0.0520 05/09/2014 01:03:17 Galway Gold (GAY

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Galway Gold (GAYGF) 0.0520 $GAYGF

Galway Gold adopts advance notice by-law, appoints new director and grants stock options
CNW Group - Fri Jan 31, 12:28PM CST
Galway Gold Inc. (TSX-V: GLW) (the "Company" is pleased to announce the approval and adoption by its board of directors (the "Board" of amendments to its by-laws to include advance notice provisions (the "Advance Notice Provision", the purpose of which is to require advance notice to be provided to the Company in circumstances where nominations of persons for election to the Board are made by shareholders of the Company (the "Shareholders" other than pursuant to: (i) a requisition of a meeting of Shareholders made pursuant to the provisions of the Business Corporations Act (New Brunswick) (the "Act"; or (ii) a Shareholder proposal made pursuant to the provisions the Act.

IIROC Trading Resumption - GLW
CNW Group - Fri Jan 10, 10:31AM CST
Trading resumes in:

IIROC Trade Resumption - Galway Gold Inc.
Newsfile Corp - Fri Jan 10, 10:27AM CST
Trading resumes in:

Galway Gold Announces Status of Exercise of Rights for Reina de Oro Option Contract, Colombia
CNW Group - Fri Jan 10, 10:17AM CST
Galway Gold Inc. (TSX V: GLW) ("Galway Gold", "Galway" or the "Company" announces that it has exercised its right to acquire the Vetas gold-silver project in the Vetas-California-Surata gold region of Colombia. The total option exercise price is approximately US $4.3 million (cash balance as of September 30, 2013 was US $13.5 million). Galway Gold has been advised that the counterparty to the Reina de Oro Option Contract has rejected the exercise of the option. Galway Gold is seeking arbitration of this matter pursuant to the terms of the Option Contract. Management feels confident of a positive outcome from the arbitration hearing based on the following facts.

IIROC: Halt, Galway Gold Inc.
Marketwire Canada - Fri Jan 10, 10:02AM CST
The following issues have been halted by IIROC / L'OCRCVM a suspendu la negociation des titres suivants :

IIROC Trading Halt - GLW
CNW Group - Fri Jan 10, 9:47AM CST
The following issues have been halted by IIROC:

Galway Gold's maiden Vetas resource averages over 10.0 g/t Au
CNW Group - Wed Nov 27, 9:44AM CST
Galway Gold Inc. (TSX-V: GLW) ("Galway Gold, Galway or the Company" is pleased to announce an initial mineral resource estimate at its Vetas gold-silver project, host of the El Volcán gold-silver mine that has been in operation for over 400 years and is the largest mine in the Vetas-California-Surata gold region of Colombia. As previously reported, Galway Gold's Vetas project was spun out of Galway Resources into Galway Gold after Galway Resources was acquired by AUX Acquisition 2 S.àr.l on December 20, 2012, for total consideration of approximately Cdn$340 million cash. Galway Gold is well capitalized with US$14.8 million of cash as of June 30, 2013, and holds an option to acquire a 100% interest in the Vetas gold project in Colombia.

Galway Gold terminates option agreement on the Coloro property
CNW Group - Fri Jul 19, 11:54AM CDT
Galway Gold Inc. (TSX-V: GLW) ("Galway Gold" or the "Company" announces that it has terminated the option agreement on the Coloro property in Vetas, Colombia. The Company conducted extensive surface sampling and geophysical programs and drilled 1,232 meters with no significant results identified. For example, the best intersections in the two Coloro holes, GLW-V069 and GLW-072, included 1.5 meters of 0.36 grams per tonne gold (g/t Au) and 1.4 m of 0.12 g/t Au. Similarly, the best surface sample results included 0.4 m of 2.58 g/t Au and 2.0 m of 0.96 g/t Au. As reported on January 22, 2013, 45% of the Coloro concession will be affected by Colombia's new Santurban Natural Park. The Reina de Oro concession, home of the El Volcan Mine and where over 45,000 meters of drilling has occurred, is not affected by the Natural Park.

Galway Gold provides corporate update and awards incentive stock options
CNW Group - Mon Jun 24, 1:04PM CDT
Galway Gold Inc. (TSX-V: GLW) ("Galway Gold" or the "Company" is pleased to announce that it has awarded 7 million incentive stock options exercisable at C$0.20 per common share and expiring on June 4, 2023, to officers, directors, employees and consultants of the Company. This is the first grant of options and is in compliance with terms of the Company's Stock Option Plan and remains subject to acceptance by the TSX Venture Exchange.

Galway Gold doubles veins identified at Vetas' El Volcan and expands mineralization to 900m u/g; in 8 new holes at least 1.0m of 100 g/t Au was intersected 3 times
CNW Group - Thu Mar 21, 5:30AM CDT
Galway Gold Inc. (TSXV: GLW) ("Galway Gold, Galway or the Company" is pleased to announce assay results from 8 underground diamond drill holes at its Vetas gold-silver project, host of the El Volcan mine. El Volcan, which has been in operation for over 400 years, and is still operating today, is the largest mine in the Vetas-California-Surata region of Colombia. Galway Gold's Vetas project was spun out to existing shareholders of Galway Resources after it was acquired by AUX on December 20, 2012 for total cash consideration of approximately Cdn$340 million. Galway Gold's exploration focus at Vetas is to test for a continuation of mineralization below the El Volcan mine, expand strike and lateral extensions to the mine, and to test 7 surface geochemical/geophysical anomalies. Galway Gold is well capitalized with US$18 million of cash and has made, and will continue to make necessary adjustments in its exploration program cognisant of the tough capital market conditions.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Triumph Financial Sets Stage for Q4 Earnings and Insights

Updated Category News Views 196

Triumph Financial Plans Fourth Quarter Earnings Release Triumph Financial, Inc. (Nasdaq: TFIN) recently announced its anticipation for the release of fourth quarter financial results. This event is scheduled to take place after the market closes on an upcoming Wednesday. Along with the financial report, the company will provide management commentary for stakeholders and...

Continue Reading
Monitoring ABA Therapy Progress: A Parent's Guide

Updated Category News Views 6

The Nuts and Bolts of Progress Monitoring You've got a situation in Leominster where parents are trying to make sense of ABA therapy's impact on their kids. Rob Shapiro, a big name in the ABA world, breaks it all down in a HelloNation article. We're talking about precise data collection being the backbone of measuring progress in ABA therapy. This ain't no place for...

Continue Reading
Understanding Dowlais Group's Recent Market Activities

Updated Category News Views 185

Public Disclosure Regarding Dowlais Group's Trading Activity FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose r

Continue Reading
OFS Credit Company Reports Impressive Q4 Financials for 2024

Updated Category News Views 98

OFS Credit Company Delivers Strong Q4 2024 Financial Results OFS Credit Company, Inc. (NASDAQ: OCCI), a notable investment firm focusing on collateralized loan obligation (CLO) equity and debt securities, has announced its financial performance for the fiscal quarter ending October 31, 2024. This report outlines the company’s significant financial growth and strategic...

Continue Reading
Breakthrough Data on HBI-8000 and Nivolumab for Melanoma

Updated Category News Views 89

HBI-8000 and Nivolumab: A New Era in Melanoma Treatment Recent findings highlight the potential of HBI-8000 in combination with nivolumab, suggesting a transformative approach in the treatment of advanced melanoma. This promising combination will be discussed in detail at an upcoming prestigious annual meeting focused on advancements in immunotherapy. Innovative Solutions...

Continue Reading